Sanofi Net Income/Loss 2010-2025 | SNY

Sanofi net income/loss for the twelve months ending March 31, 2025 was $8.366B, a 12.71% decline year-over-year.

  • Sanofi annual net income/loss for 2024 was $5.947B, a 1.76% increase from 2023.
  • Sanofi annual net income/loss for 2023 was $5.844B, a 33.73% decline from 2022.
  • Sanofi annual net income/loss for 2022 was $8.82B, a 19.79% increase from 2021.

Sanofi Net Income/Loss 2010-2025 | SNY

  • Sanofi annual net income/loss for 2024 was $5.947B, a 1.76% increase from 2023.
  • Sanofi annual net income/loss for 2023 was $5.844B, a 33.73% decline from 2022.
  • Sanofi annual net income/loss for 2022 was $8.82B, a 19.79% increase from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$796.4B
Johnson & Johnson (JNJ)$379.5B
AbbVie (ABBV)$306B
Novo Nordisk (NVO)$260.6B
Roche Holding AG (RHHBY)$248.1B
Novartis AG (NVS)$234.2B
Merck (MRK)$196.7B
Pfizer (PFE)$125.6B
Bayer (BAYRY)$23.7B
Innoviva (INVA)$1.1B